Hepatitis C

• FDA label_change · 2020-07-14
  FDA Approved: EPCLUSA — Supplemental Application (Gilead Sciences, Inc.)

  FDA approved a supplemental application for Epclusa (velpatasvir/sofosbuvir) from Gilead to update the product labeling.

• FDA label_change · 2019-09-26
  FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)

  FDA approved a supplemental application for MAVYRET (glecaprevir and pibrentasvir) from AbbVie. The action updates the product labeling to r…